Perceptions about preclinical Alzheimer's disease biomarker collection procedure influences willingness to participate: Findings from an ethnoracially diverse study

被引:0
|
作者
Gooding, Diane Carol [1 ,2 ,3 ]
Van Hulle, Carol A. [3 ,4 ]
Zuelsdorff, Megan [5 ]
Lewis, Jordan P. [6 ]
Carter, Fabu P. [4 ]
Salazar, Hector [3 ,4 ]
Bouges, Shenikqua [3 ,4 ,7 ]
James, Taryn T. [3 ,4 ]
Gee, Alexander [8 ]
Gleason, Carey E. [3 ,4 ,9 ]
机构
[1] UW Madison, Dept Psychol, Madison, WI USA
[2] UW Madison, Sch Med & Publ Hlth, Dept Psychiat, Madison, WI USA
[3] UW Madison, Sch Med & Publ Hlth, Dept Med, Geriatr & Gerontol, Madison, WI USA
[4] UW Madison, Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA
[5] UW Madison, Sch Nursing, Madison, WI USA
[6] Univ Minnesota, Med Sch, Duluth Campus, Duluth, MN USA
[7] Middleton Mem Hosp, Madison VA GRECC, Madison, WI USA
[8] Nehemiah Ctr Urban Leadership Dev, Madison, WI USA
[9] UW Madison, Wisconsin Alzheimers Inst, Sch Med & Publ Hlth, Madison, WI USA
关键词
Alzheimer's disease; biomarker testing; blood-based biomarkers; brain scanning; lumbar puncture; race/ethnicity; research attitudes; research participation; testing willingness; BIOMEDICAL-RESEARCH; DEMENTIA; HEALTH;
D O I
10.1177/13872877241307255
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Past research suggests that ethnoracialized groups differ in their willingness to engage in preclinical Alzheimer's disease (AD) research overall. Studies indicated that participation willingness was affected by attitudes toward research and perceived invasiveness of biomarker collection techniques. However, comparative quantitative studies are few, and minoritized groups are under-included. Objective: In a cross-sectional online survey, we sought to explore community-based adults' willingness to engage in preclinical AD biomarker testing, comparing their attitudes about research and different types of biomarker procedures. Methods: We conducted an online survey with a diverse group of participants. African American (AA), American Indian/Alaska Native (AI/AN), Latinx (LTX), and Non-Hispanic White (NHW) adults aged 26-90 were asked about their research attitudes, biomarkers, and willingness to participate in specific biomarker test procedures (i.e., brain imaging via PET scanning, blood draws, and cerebrospinal fluid collection by lumbar puncture). We also assessed participants' perceived safety, burden, and distress for each of the three biomarker collection methods. To understand the association between research willingness and ethnoracial identity, we ran linear regression models for each procedure, adjusting for age, gender, educational attainment, and attitudes toward research. Results: The AA group expressed greater willingness to engage in biomarker testing involving blood draws than the NHW group. The AI/AN group was significantly less willing to undergo lumbar puncture than the NHW group; this difference remained after adjusting for various sociodemographic factors and research attitudes. Conclusions: Respondents' willingness to engage in preclinical AD biomarker research was affected by their perceptions about the testing collection procedure.
引用
收藏
页码:865 / 878
页数:14
相关论文
共 50 条
  • [41] EBF1 is a potential biomarker for predicting progression from mild cognitive impairment to Alzheimer's disease: an in silico study
    Ju, Yanxiu
    Li, Songtao
    Kong, Xiangyi
    Zhao, Qing
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [42] No increased risk of Alzheimer's disease among people with immune-mediated inflammatory diseases: findings from a longitudinal cohort study of US older adults
    Booth, Michael J.
    Kobayashi, Lindsay C.
    Janevic, Mary R.
    Clauw, Daniel
    Piette, John D.
    BMC RHEUMATOLOGY, 2021, 5 (01)
  • [43] A Western-style dietary pattern is associated with cerebrospinal fluid biomarker levels for preclinical Alzheimer's disease-A population-based cross-sectional study among 70-year-olds
    Samuelsson, Jessica
    Kern, Silke
    Zetterberg, Henrik
    Blennow, Kaj
    Rothenberg, Elisabet
    Wallengren, Ola
    Skoog, Ingmar
    Zettergren, Anna
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2021, 7 (01)
  • [44] Predicting the onset of Alzheimer's disease and related dementia using electronic health records: findings from the cache county study on memory in aging (1995-2008)
    Schliep, Karen C.
    Thornhill, Jeffrey
    Tschanz, JoAnn T.
    Facelli, Julio C.
    Ostbye, Truls
    Sorweid, Michelle K.
    Smith, Ken R.
    Varner, Michael
    Boyce, Richard D.
    Cliatt Brown, Christine J.
    Meeks, Huong
    Abdelrahman, Samir
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2024, 24 (01)
  • [45] Temporal trend and attributable risk factors of Alzheimer's disease and other dementias burden in China: Findings from the Global Burden of Disease Study 2021
    Yang, Kun
    Yang, Xuan
    Yin, Peng
    Zhou, Maigeng
    Tang, Yi
    ALZHEIMERS & DEMENTIA, 2024, 20 (11) : 7871 - 7884
  • [46] The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer's Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
    Yatawara, Chathuri
    Zailan, Fatin Zahra
    Chua, Esther Vanessa
    Lim, Linda Lay Hoon
    Silva, Eveline
    Wang, Joanna Sihan
    Ng, Adeline
    Ng, Kok Pin
    Kandiah, Nagaendran
    CLINICAL INTERVENTIONS IN AGING, 2021, 16 : 301 - 309
  • [47] Prescription Patterns of Antidementia and Psychotropic Drugs in People Living With Dementia: Findings From the Clinical Pathway Study of Alzheimer's Disease in China
    Zhang, Yingyang
    Luo, Hao
    Wong, Gloria H. Y.
    Zhao, Mei
    Lv, Xiaozhen
    Lum, Terry Y. S.
    Chui, Celine S. L.
    Yu, Xin
    Wong, Ian C. K.
    Wang, Huali
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2022, 23 (06) : 1073 - +
  • [48] A concise and persistent feature to study brain resting-state network dynamics: Findings from the Alzheimer's Disease Neuroimaging Initiative
    Kuang, Liqun
    Han, Xie
    Chen, Kewei
    Caselli, Richard J.
    Reiman, Eric M.
    Wang, Yalin
    Weiner, Michael W.
    Aisen, Paul
    Weiner, Michael
    Petersen, Ronald
    Jack, Clifford R., Jr.
    Jagust, William
    Trojanowki, John Q.
    Toga, Arthur W.
    Beckett, Laurel
    Green, Robert C.
    Saykin, Andrew J.
    Morris, John
    Shaw, Leslie M.
    Khachaturian, Zaven
    Sorensen, Greg
    Carrillo, Maria
    Kuller, Lew
    Raichle, Marc
    Paul, Steven
    Davies, Peter
    Fillit, Howard
    Hefti, Franz
    Holtzman, David
    Mesulam, M. Marcel
    Potter, William
    Snyder, Peter
    Lilly, Eli
    Logovinsky, Veronika
    Montine, Tom
    Jimenez, Gustavo
    Donohue, Michael
    Gessert, Devon
    Harless, Kelly
    Salazar, Jennifer
    Cabrera, Yuliana
    Walter, Sarah
    Hergesheimer, Lindsey
    Harvey, Danielle
    Bernstein, Matthew
    Fox, Nick
    Thompson, Paul
    Schuff, Norbert
    DeCArli, Charles
    Borowski, Bret
    HUMAN BRAIN MAPPING, 2019, 40 (04) : 1062 - 1081
  • [49] Delayed help seeking behavior in dementia care: preliminary findings from the Clinical Pathway for Alzheimer's Disease in China (CPAD) study
    Zhao, Mei
    Lv, Xiaozhen
    Tuerxun, Maimaitirexiati
    He, Jincai
    Luo, Benyan
    Chen, Wei
    Wang, Kai
    Gu, Ping
    Kuang, Weihong
    Zhou, Yuying
    Qu, Qiumin
    He, Jianhua
    Zhang, Nan
    Feng, Yongping
    Wang, Yanping
    Yu, Xin
    Wang, Huali
    INTERNATIONAL PSYCHOGERIATRICS, 2016, 28 (02) : 211 - 219
  • [50] The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease
    Mohs, Richard C.
    Beauregard, Douglas
    Dwyer, John
    Gaudioso, Jennifer
    Bork, Jason
    MaGee-Rodgers, Tamiko
    Key, Mickeal N.
    Kerwin, Diana R.
    Hughes, Lynn
    Cordell, Cyndy B.
    ALZHEIMERS & DEMENTIA, 2024, 20 (04) : 2752 - 2765